Harmony Biosciences Holdings, Inc. HRMY Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.
The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Harmony Biosciences Holdings, Inc.'s deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Harmony Biosciences Holdings, Inc.'s deferred tax assets?
- Harmony Biosciences Holdings, Inc. (HRMY) reported deferred tax assets of $153.56M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s deferred tax assets changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s deferred tax assets decreased by 21.1% year-over-year, from $194.71M to $153.56M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s deferred tax assets?
- Over 3 years (2022 to 2025), Harmony Biosciences Holdings, Inc.'s deferred tax assets has grown at a 20.3% compound annual growth rate (CAGR), from $85.94M to $149.7M.
- What does deferred tax assets mean?
- Represents future tax benefits arising from temporary differences between the book value of assets/liabilities and their tax basis, or from carry-forward tax losses. These assets are realized when the firm generates sufficient taxable income to offset these differences. It serves as an indicator of future tax savings potential.